Prem Watsa RVNC Holdings History

Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-17,772.72
% of Total Estimate Gain
-19.35%

Prem Watsa's Revance Therapeutics Inc Holding Summary

As of 2025-03-31, Fairfax Financial Holdings held - shares of Revance Therapeutics Inc(RVNC), totaling N/A. This investment constitutes 0% of their stock portfolio, and Fairfax Financial Holdings now holds 0% of the outstanding Revance Therapeutics Inc(RVNC) stock.

The initial trade took place in 2024Q4. And since then Prem Watsa has made 1 purchases of RVNC, at an average price of $4.34, for a total of 21,158.00 shares. In addition, there have been 1 sales at an average price of $3.50 for 21,158.00 shares. Based on historical transaction data and RVNC's current price of $3.65, Prem Watsa's estimated gain on his RVNC holdings is $-17,772.72, reflecting a -19.35% gain to date.

Prem Watsa RVNC ($3.65) Holding Chart

Prem Watsa RVNC ($3.65) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1